Does anyone have information about the auto-immune value and/or reversibility of LADA (latent auto-immune diabetes for adults) using LDN (low-dose naltrexone) as recommended by highly-regarded supernutritionist Julian Whitaker, MD?
LDN Boosts Immune Function
It would be several years before the mechanisms were understood, but we now know that when LDN is taken at bedtime, it binds to opioid receptors and temporarily blocks endorphins from attaching. This action signals the body to increase endorphin production, an effect that can last as long as 18 hours.
Opioid receptors aren’t exclusive to the brain. They’re also present on all types of immune cells,
including macrophages, natural killer cells, T- and B-cells, and even stem cells. As a result, the flood of endorphins set into motion by LDN stimulates the immune system and enhances the body’s ability to fight disease.
The benefits of this remarkable drug have been proven in a number of scientific studies, several of which were presented at the Fourth Annual LDN Conference recently held on the campus of the University of Southern California School of Medicine.
Low dose naltrexone (LDN)
Main article: Low dose naltrexone
Low dose naltrexone (LDN), where the drug is used in doses approximately one-tenth those used for drug/alcohol rehabilitation purposes, is being used by some as an "off-label" experimental treatment for certain immunologically-related disorders, including HIV/AIDS, multiple sclerosis (in particular, the primary progressive variant,) Parkinson's disease, cancer, fibromyalgia, autoimmune diseases such as rheumatoid arthritis or ankylosing spondylitis, Crohn's disease, ulcerative colitis, Hashimoto's thyroiditis, and central nervous system disorders.
Next Discussion: All the news that's fit to print! »